Dr. Lusso received his M.D., summa cum laude, from the University of Turin and his Ph.D. from the Ministry of Scientific and Technologic Research, Rome, Italy. He is a board-certified specialist in internal medicine and in infectious diseases. From 1986 to 1994 he worked as a Visiting Scientist in the Laboratory of Tumor Cell Biology, NCI, Bethesda, MD. From 1994 to 2007, he directed the AIDS Research Laboratory at the San Raffaele Institute in Milan, Italy, and became associate professor of infectious diseases at the University of Cagliari. In 2007, he returned to the US to became the Chief of the Viral Pathogenesis Section in the Laboratory of Immunoregulation, NIAID, Bethesda. He is an elected Member of the European Molecular Biology Organization (EMBO) and a Fellow of the American Academy of Microbiology. His research is focused on the mechanisms of HIV/AIDS pathogenesis and the development of an HIV vaccine. His 1995 discovery of the HIV-suppressive chemokines was nominated “Breakthrough of the Year” by Science magazine.
